Study: Patients Use Only About Half of Opioids Prescribed After Hysterectomy

A U-M gynecologist emphasizes a personalized approach to post-surgical prescriptions to help prevent chronic opioid use.

7:00 AM

Author | Beata Mostafavi

Doctors may be prescribing nearly twice the number of opioids than the average patient needs after a hysterectomy, a new study suggests.

MORE FROM THE LAB: Subscribe to our weekly newsletter

Researchers at the University of Michigan tracked opioid use in roughly 100 women two weeks after undergoing a hysterectomy for benign reasons. Women were commonly prescribed about 40 hydrocodone pills but on average had nearly 22 left over, according to the findings published in the December issue of The Green Journal, the official publication of the American College of Obstetricians and Gynecologists.

"A hysterectomy is the most common surgical procedure performed in nonpregnant women, which is why this is a critical target for improvement in opioid prescribing," says lead author Sawsan As-Sanie, M.D., MPH, a gynecological surgeon at U-M's Von Voigtlander Women's Hospital and an assistant professor of obstetrics and gynecology at the U-M Medical School.

"Our findings confirm that within our specialty, there is a similar pattern of opioid prescribing as we are seeing in other surgical populations. We found that a small but meaningful portion of patients did not need any opioids after hysterectomy, and most were given far more opioids than they said they used."

The study included 102 participants, each receiving either a laparoscopic (44, or 43.1 percent), vaginal (42, or 41.2 percent) or abdominal (16, or 15.7 percent) hysterectomy. Patients reported opioid consumption two weeks after hysterectomy through telephone surveys and written documentation.

Overall, 97 percent of women reported adequate pain control, and 40 percent felt they received more opioids than needed after surgery. Several individual patient characteristics, such as chronic pain elsewhere in the body prior to surgery, were associated with higher-than-average opioid use after hysterectomy.

Among gynecologic procedures, hysterectomy is the most frequently performed surgery after cesarean section. Roughly 600,000 hysterectomies are performed each year in the U.S., with nearly 20 million American women having one. Studies report that by age 60, more than one-third of women have had a hysterectomy.

We found that a small but meaningful portion of patients did not need any opioids after hysterectomy, and most were given far more opioids than they said they used.
Sawsan As-Sanie, M.D., MPH

Tailoring to patients

As-Sanie notes that it's important for doctors to take a personalized approach when prescribing opioids after hysterectomy.

SEE ALSO: To Reduce Hysterectomy-Related Readmissions, Target Those at Risk

"There is a lot of variability among post-surgical patients," As-Sanie says. "As we move more toward precision medicine and tailoring recommendations to individual patients, we hope to better identify specific patient factors that may be associated with how much pain medication should be prescribed."

"These studies will help us better understand what each patient needs for adequate pain management after these procedures."

The study contributes to the efforts of the Michigan Opioid Prescribing Engagement Network (Michigan-OPEN), which aims to halve both the number of opioids prescribed to Michigan surgical patients and the number of patients who still use opioids months after surgery. The Michigan-OPEN team will lead the University of Michigan's new Precision Health Research Initiative to identify risk factors that may increase the likelihood of someone becoming a chronic opioid user after surgery.

As-Sanie collaborated on the recent study with senior author Chad Brummett, M.D., one of Michigan-OPEN's leaders and director of the Division of Pain Research in the U-M Department of Anesthesiology.

"By educating both patients and surgeons involved with gynecologic procedures, we can significantly reduce the amount of excess opioids in the community without harming patients," As-Sanie says.


More Articles About: Rounds hysterectomy Pain management Womens Health
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories Hysterectomy Image
Health Lab
Simple Conversations Can Reduce Opioid Prescriptions After Hysterectomy
Involving hysterectomy patients in their pain management decisions led to significantly decreased opioid prescriptions.
pills spilling out of bottle
Health Lab
Primary care physicians are hesitant to accept chronic pain patients using opioids or cannabis
Michigan Medicine research finds that patients with chronic pain who use either substance may find it harder to find primary care physician than those who don’t.
Nociplastic pain researchers Chelsea Kaplan, Steven Harte, Andrew Schrepf, Dan Clauw
Department News
What we know about nociplastic pain
A new review article shines light on nociplastic pain, a type of pain some thought to be ‘all in your head’
mushrooms in a microscope
Health Lab
How cannabis and psilocybin might help some of the 50 million Americans experiencing chronic pain
Recent developments represent a dramatic change from long standing federal policy around these substances that has historically criminalized their use and blocked or delayed research efforts into their therapeutic potential.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Cannabis and psychedelics: stigmatized substances or powerful therapeutics?
Today on The Fundamentals is Dr. Kevin Boehnke, research assistant professor in the Department of Anesthesiology and the Chronic Pain and Fatigue Research Center. His current research focuses on therapeutic applications of cannabis and psychedelics. His goal is to rigorously assess appropriate use of these substances and to help address the public health harms caused by their criminalization.
marijuana leaf drawing blue lab note yellow badge upper left corner
Health Lab
Data shows medical marijuana use decreased in states where recreational use became legal 
Data on medical cannabis use found that enrollment in medical cannabis programs increased overall between 2016 and 2022, but enrollment in states where nonmedical use of cannabis became legal saw a decrease in enrollment